Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease

Background. The aim of this study was to establish a hepatitis B virus (HBV) vaccination protocol among orthotopic liver transplantation (OLT) recipients under the coverage of a low-dose hepatitis B immunoglobulin (HBIG) combined with an antiviral agent prophylaxis protocol. Method. Two hundred OLT...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shi-Chun Lu, Tao Jiang, Wei Lai, Yuan Liu, Jing Zhang, Dao-Bing Zeng, Chuan-Yun Li, Meng-Long Wang, Dong-Dong Lin, Yue Zhu, You-Ping Li, Ning Li
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2014/764234
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft
by: V. Ye. Syutkin, et al.
Published: (2010-04-01)

STING modulates HBV-related acute-on-chronic liver failure by mediating autophagy and macrophage polarization
by: Hao Zhang, et al.
Published: (2025-01-01)

Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
by: Marco Delle Monache, et al.
Published: (2021-01-01)

Hepatocellular Carcinoma Metastasis to the Orbit in a Coinfected HIV+ HBV+ Patient Previously Treated with Orthotopic Liver Transplantation: A Case Report
by: S. Guerriero, et al.
Published: (2011-01-01)

Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis
by: Yaqin Chen, et al.
Published: (2015-01-01)

Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV/HCV infection: an 11-year retrospective cohort study in Guangxi, China
by: Jun Yu, et al.
Published: (2019-04-01)

Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure
by: Lin Lin, et al.
Published: (2022-01-01)

The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive
by: Yan Guo, et al.
Published: (2022-01-01)

Modelling and Simulation of The Spread of HBV Disease.
by: Niyirora, Ignatius
Published: (2023)

Modelling and Simulation of the Spread of HBV Disease.
by: Niyirora, Ignatius
Published: (2024)

Clinical Relevance of HLA Gene Variants in HBV Infection
by: Li Wang, et al.
Published: (2016-01-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Disproportionate Distribution of HBV Genotypes A and D and the Recombinant Genotype D/E in the High and Low HBV Endemic Regions of Uganda: A Wake-Up Call for Regional Specific HBV Management
by: Hussein Mukasa Kafeero, et al.
Published: (2022-01-01)

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01)

A new prognostic model based on serum apolipoprotein AI in patients with HBV-ACLF and acutely decompensated liver cirrhosis
by: Ruidong Mo, et al.
Published: (2025-02-01)

Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases
by: Yanqiang Liao, et al.
Published: (2024-01-01)

miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD)
by: Parthana Rani Sutradhar, et al.
Published: (2024-01-01)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
by: Dong-Mei Zhu, et al.
Published: (2020-01-01)

An Exceptional Case of Liver-Restricted High-Grade B-Cell Lymphoma in a Patient with Clinical History of HBV and HCV Coinfections
by: Connor R. Zuraski, et al.
Published: (2019-01-01)

Pharmacophore modeling and QSAR analysis of anti-HBV flavonols.
by: Basireh Baei, et al.
Published: (2025-01-01)

Analysis of a HBV Model with Diffusion and Time Delay
by: Noé Chan Chí, et al.
Published: (2012-01-01)

The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis
by: Jiao Yang, et al.
Published: (2016-01-01)

Correlation of Chimerism with Acute Graft-versus-Host Disease in Rats following Liver Transplantation
by: Fei Xue, et al.
Published: (2011-01-01)

Stability Analysis and Clinic Phenomenon Simulation of a Fractional-Order HBV Infection Model
by: Yongmei Su, et al.
Published: (2020-01-01)

HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
by: Raj Kalkeri, et al.
Published: (2020-01-01)

Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01)

Dynamics of a diffusive age-structured HBV model with saturating incidence
by: Xichao Duan, et al.
Published: (2016-06-01)

Structure of small HBV surface antigen reveals mechanism of dimer formation
by: Xiao He, et al.
Published: (2025-01-01)

Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study
by: Miguel Moncayo, et al.
Published: (2024-01-01)

The sex differences in diseases progression and prognosis among persons with HIV and HBV coinfection
by: Rongrong Yang, et al.
Published: (2025-02-01)

Hepatitis B virus infections in pregnant women and children in the era of HBV elimination
by: Malgorzata Pawlowska
Published: (2024-12-01)

Feedback control of an HBV model based on ensemble kalman filter and differential evolution
by: Junyoung Jang, et al.
Published: (2018-05-01)

Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients
by: Edward Kim, et al.
Published: (2021-01-01)

Chronic glomerulonephritis of the mixed type in patient with HBV-infection (<i>Clinical case</i>)
by: V. S. Adonyeva, et al.
Published: (2013-07-01)

The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis
by: Youmin Pan, et al.
Published: (2022-01-01)

Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection
by: Marcos Daniel Mendes Padilha, et al.
Published: (2025-01-01)

Immunomodulatory effect of hepatitis B virus (HBV) antigens and MRSA antigens on immune response
by: Entidhar A. Hadi, et al.
Published: (2024-01-01)

Unveiling the Molecular Architecture of HBV Spherical Subviral Particles: Structure, Symmetry, and Lipid Dynamics
by: Sonal Garg, et al.
Published: (2024-12-01)

Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations
by: Loreta A. Kondili, et al.
Published: (2025-02-01)

Effect of Chronic Hepatitis B Virus (HBV) Infection on Lipid Profile in Iraqi Patients
by: Amnah Raad Ibrahim, et al.
Published: (2023-12-01)